Search
forResearch 10 of 1000+
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Generic vs. Disease-Specific Patient Reported Outcome (PRO) Instruments for Assessing HRQoL Burden Among Patients Diagnosed with Alopecia Areata: Evidence from TARGET-DERM AA
- [ADAPTIVE REGULATORY MECHANISMS OF ALOPECIA AREATA].
- The Changing Landscape of Alopecia Areata: The Translational Landscape
- Cross‐sectional study of hair loss patterns in 122 Korean systemic lupus erythematosus patients: A frequent finding of non‐scarring patch alopecia
- A study of clinical and dermoscopic features in alopecia areata at a tertiary referral center